Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

ClinicalTrials.gov ID: NCT03943147

Public ClinicalTrials.gov record NCT03943147. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 12:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of BMS-986165 With Background Treatment in Subjects With Lupus Nephritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and effectiveness of BMS-986165 compared with placebo with regard to measures of kidney function in participants with lupus nephritis (LN).

Study identification

NCT ID
NCT03943147
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
16 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 15, 2019 (Actual)
Primary completion
Oct 29, 2020 (Actual)
Completion
Sep 17, 2021 (Actual)
Last update posted
Oct 17, 2022

2019 – 2021

United States locations

U.S. sites
40
U.S. states
23
U.S. cities
34
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294-3300 —
The Nephrology Group Fresno California 93720 —
The Regents of The University of California Los Angeles California 90095 —
University of Colorado School of Medicine Aurora Colorado 80045 —
Local Institution - 0029 Gainesville Florida 32603 —
Emory University Atlanta Georgia 30303 —
Augusta University Augusta Georgia 30912 —
Atlanta Nephrology Referral Center Lawrenceville Georgia 30046 —
Northwestern Medical Faculty Foundation Chicago Illinois 60611-5966 —
The University of Chicago Medicine Chicago Illinois 60637 —
Nephrology Associates of Northern Illinois and Indiana - Fort Wayne Fort Wayne Indiana 46804 —
Johns Hopkins University, Office of Research Administration Baltimore Maryland 21205 —
Renal and Transplant Associates of New England, PC Springfield Massachusetts 01107 —
Brighton Center for Specialty Care Brighton Michigan 48116 —
Clinical Research Consultants - Kansas City Kansas City Missouri 64111 —
Washington University School of Medicine St Louis Missouri 63110 —
Rutgers New Jersey Medical School Newark New Jersey 07103 —
Institute for Rheumatic and Autoimmune Diseases Summit New Jersey 07901 —
NewYork-Presbyterian Queens Fresh Meadows New York 11365 —
Northwell Health Physician Partners at Great Neck Great Neck New York 11021 —
Local Institution - 0039 New York New York 10016 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Columbia University Medical Center New York New York 10032 —
State University of New York Upstate Medical University Syracuse New York 13210-2342 —
East Carolina University Physicians Greenville North Carolina 27834 —
Ohio State University, Wexner Medical Center Columbus Ohio 43210 —
Local Institution - 0066 Oklahoma City Oklahoma 73104 —
Northeast Clinical Research Center Bethlehem Pennsylvania 18017 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Temple University Hospital Philadelphia Pennsylvania 19140 —
Rhode Island Hospital Providence Rhode Island 02903 —
Local Institution - 0030 Charleston South Carolina 29425 —
Office of Ramesh C. Gupta, MD Memphis Tennessee 38119 —
Nephrotex Research Group Dallas Texas 75231 —
Dallas Nephrology Associates - North Office Dallas Texas 75240 —
El Paso Medical Research Institute El Paso Texas 79902 —
The University of Texas Health Science Center at Houston Houston Texas 77030 —
University of Utah Salt Lake City Utah 84132 —
Virginia Mason Medical Center Seattle Washington 98101 —
University of Washington School of Medicine Seattle Washington 98195-6340 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03943147, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 17, 2022 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03943147 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →